Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/457
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajapakse, S.-
dc.contributor.authorRodrigo, C.-
dc.contributor.authorRajapakse, A.-
dc.contributor.authorKirthinanda, D.-
dc.contributor.authorWijeratne, S.-
dc.date.accessioned2011-11-21T10:58:02Z-
dc.date.available2011-11-21T10:58:02Z-
dc.date.issued2009-
dc.identifier.citationSaudi J Kidney Dis Transpl. 2009 Jul;20(4):553-9en_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/457-
dc.description.abstractAcute renal failure (ARF) is a common complication of sepsis and carries a high mortality. Renal replacement therapy (RRT) during the acute stage is the mainstay of therapy. Va-rious modalities of RRT are available. Continuous RRT using convective methods are preferred in sepsis-induced ARF, especially in hemodynamically unstable patients, although clear evidence of benefit over intermittent hemodialysis is still not available. Peritoneal dialysis is clearly inferior, and is not recommended. Early initiation of RRT is probably advantageous, although the optimal timing of dialysis is yet unknown. Higher doses of RRT are more likely to be beneficial. Use of bio-compatible membranes and bicarbonate buffer in the dialysate are preferred. Anticoagulation during dialysis must be carefully adjusted and monitored.en_US
dc.language.isoenen_US
dc.titleRenal replacement therapy in sepsis-induced acute renal failureen_US
dc.typeJournal abstracten_US
Appears in Collections:Department of Clinical Medicine

Files in This Item:
File Description SizeFormat 
abs.txt860 BTextView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.